Ask a question. Get a source-grounded answer with citations.
Based on 2 verified sources covering Myanmar, Thailand:
OSAKA -- Nitto Denko will partner with U.S. pharmaceutical giant Bristol-Myers Squibb to develop and sell next-generation biomedicine for advanced liver fibrosis set to go on the market as early as 2018, the latest in an array of promising drug candi... [1]
By Sonny Inbaraj/Darwin, Australia Monday, July 12, 2004 By Sonny Inbaraj/Darwin, Australia Monday, July 12, 2004 By Sonny Inbaraj/Darwin, Australia Monday, July 12, 2004 [2]
Note: This briefing is based on limited source coverage. The evidence may be incomplete or outdated.
OSAKA -- Nitto Denko will partner with U.S. pharmaceutical giant Bristol-Myers Squibb to develop and sell next-generation biomedicine for advanced liver fibrosis set to go on the market as early as 2018, the latest in an array of promising drug candi
By Sonny Inbaraj/Darwin, Australia Monday, July 12, 2004 By Sonny Inbaraj/Darwin, Australia Monday, July 12, 2004 By Sonny Inbaraj/Darwin, Australia Monday, July 12, 2004